Published: November 10, 2016

Introduction {#sec1}
============

RNA sequencing (RNA-seq) has quickly become the standard method for transcriptomics ([@bib53]) and has been further developed into a number of modified protocols that allow detection from single cells (single-cell RNA-seq \[scRNA-seq\]) ([@bib46]). The power of scRNA-seq to reveal cell population heterogeneity in transcriptome-wide fashion has made it the focus of intense recent research activity aimed at its further development and on analysis techniques (e.g., [@bib10], [@bib25], [@bib34]).

The typical workflow of an RNA-seq assay involves the extraction (and often further purification) of mRNA from cells, the preparation of a sequencing library including fragmentation, linear ([@bib13]) or PCR amplification, next-generation sequencing, and computational processing and analysis of the resulting data. Although a great variety of different RNA-seq protocols have been developed, virtually all (except for direct RNA sequencing \[[@bib35]\]) include the basic cDNA production steps of reverse transcription (often referred to as first-strand synthesis) and second-strand synthesis, which often corresponds to an extended first cycle of the subsequent PCR amplification ([Figure 1](#fig1){ref-type="fig"}A). The cDNA replaces the less robust RNA with DNA and is required for the introduction of adapters to enable next-generation sequencing, unless special adaptions are used ([@bib8]). The enzymes used in cDNA production are processive ([@bib51]) and thus incorporate many nucleotides before the reaction stops. The exact syntheses starting and stopping points are unclear and introduce complex positional dependencies, which are crucial for the resulting RNA-seq coverage ([Figure 1](#fig1){ref-type="fig"}B).

Several steps in the library preparation procedures lead to over- and/or under-representation of sequences with regards to the starting material, introducing biases in the RNA-seq quantification. This can be partially experimentally corrected by employing molecular barcodes ([@bib22]), although these have other disadvantages, such as PCR and sequencing errors that bias results ([@bib31]). Some types of bias, such as non-uniform primer binding ([@bib12]) or fragmentation efficiency ([@bib9], [@bib37]), affect the local coverage within transcripts and can be computationally corrected to a degree. However, the vast majority of (sc)RNA-seq datasets show peculiar *global* shapes, that is an overall pattern concerning transcript coverages that depends on the transcripts' lengths (see below, [Results](#sec2){ref-type="sec"}, and glossary for terms we use in [Box 1](#tbox1){ref-type="boxed-text"}). It was noted before that this is probably due to cDNA production (see below) ([@bib33]). However, the effect remains uncorrected by analysis tools ([@bib44]) and is not understood, and the systematic bias it introduces is potentially much stronger than local variation.

Since the major goal of RNA-seq is to accurately infer (relative) expression levels or sequence structure of the original mRNAs, these biases are problematic and need to be taken into account. This issue is particularly relevant for scRNA-seq, where absolute transcript quantification is desired and where the bias in coverage by sequencing reads can affect sensitivity. While losses at each step of a standard RNA-seq protocol are uncritical due to a sufficient supply of starting material, they limit chances of transcript detection and absolute quantification in scRNA-seq. Ideally, the mass of every single original mRNA should be harnessed as completely as possible for the next-generation sequencing step at the end of an scRNA-seq protocol. To do that, one must understand systematic non-uniformities in scRNA-seq coverage.

In the present work, we introduce an analytical and computational framework that allows "reverse engineering" of reactions and enzyme kinetics during RNA-seq library preparation. Applying this framework, we are able to identify polymerase processivities as the main determinants for the global coverage shapes. Our models also yield correction factors for quantification, which demonstrate that currently used measures are inadequate. The insights into molecular reactions that our framework allows can be further exploited to improve RNA-seq protocols, as we demonstrate experimentally.

Results {#sec2}
=======

Below, we will analyze a selection of RNA-seq strategies, mostly for scRNA-seq, but covering virtually all widely used protocols, and focus on the coverage by sequencing reads along transcripts. The main variation between these protocols concerns the first- and second-strand priming strategies.

The first published scRNA-seq strategy ([@bib45]), which we term the poly-A-tagging protocol, is designed to ligate a second-strand primer to an adenine stretch that is added by terminal transferase to the end of the poly-A tail-primed first-strand. Thus, coverage critically depends on where reverse transcription stops. An improved version of this protocol was published as "Quartz-seq" ([@bib41]). By contrast, complete ("full-length") sequencing coverage along the whole mRNA has been a selling point of different library preparation protocols, as it is believed to correspond to more reads per transcript and/or better resolution of splice variants ([@bib36], [@bib38]). Particularly successful in this respect is the second scRNA-seq approach we are studying, termed "Switching Mechanism At the 5′ terminus of the RNA Transcript" (SMART) ([@bib57]). Here, the second-strand primer binds to the overhang generated by the addition of several non-templated cytosines by the reverse transcriptase upon completion of full-length of the first-strand, which is primed from the poly-A tail. SMART-based scRNA-seq, and its variants (e.g., "Smart-seq2"), has become a de facto standard ([@bib7], [@bib21], [@bib36], [@bib38], [@bib42]). Both poly-A-tagging and SMART protocols are usually subjected to variable numbers of PCR cycles. An extended first PCR cycle is used to synthesize the second-strand, while later cycles also enrich *complete* second strands by using primers flanking the 3′ ends of first-strands.

While the bulk of our analysis will be devoted to methods derived from poly-A tagging and SMART, we will also briefly discuss the linear-amplification-based scRNA-seq strategy CEL-seq ([@bib13], [@bib14]). CEL-seq compares unfavorably to the above scRNA-seq protocols in some studies in terms of its technical variation ([@bib3]) and is based on a complex sequence of enzymatic conversions; the mRNAs are reverse transcribed based on poly-A priming using molecular barcode containing primers, followed by random-primed second-strand synthesis, in vitro transcription, RNA fragmentation, and another round of first- and second-strand syntheses. Finally, only fragments containing the 3′ end with regards to the original mRNA are selected by PCR. Inference of expression levels is based on counting these fragments and/or unique barcodes, while coverage along transcripts is ignored. CEL-seq thus follows a different principle than the other protocols.

In addition to these single-cell techniques, we include two bulk methods for comparison. First, we analyze the classical RT-PCR/RNA-seq protocol based on random-oligonucleotide primed first-strand synthesis, followed by randomly primed second-strand synthesis based on RNaseH-nicking ([@bib6]) (with fragmentation after cDNA production). This priming strategy is not common in scRNA-seq, as the usage of 3′ poly-A tail binding primers reduces priming of rRNA, thus making purification of mRNA unnecessary and potentially reducing losses of the limiting starting material. However, it provides a useful comparison because it gives rise to very different coverages as the above protocols and is still commonly employed for qPCR. Second, we include an RNA-fragmentation-based dataset ([@bib50]), which fragments mRNA instead of cDNA and thus strongly reduces the coverage bias due to cDNA-production. While this is routinely applied in standard RNA-seq, it is not used for scRNA-seq, presumably for fear of degrading and losing mRNA and because it precludes direct poly-A priming. This allows us to compare above protocols to a popular and potentially bias-free one.

The principles of the above mentioned RNA-seq protocols are mostly based on assumptions, and it is unclear how closely these reflect the experimental reality. It has been pointed out before, for instance, that SMART protocols may increase the portion of full-length products in the final reaction mixture by excluding incomplete first-strand synthesis products (due to reduced efficiency of the SMART mechanism inside the mRNA compared to its end), rather than by improving or completing their synthesis ([@bib15], [@bib43]). We wanted to explore from a general and quantitative perspective how reliable the above assumptions are and what trade-offs between complete coverage, loss of starting material, and position bias are to be expected for the various protocols.

Thus, we visualized the sequencing read distributions in actual datasets generated by a variety of RNA-seq and scRNA-seq library preparation protocols. We group protocols into poly-A tagging-like, SMART-like, random priming, CEL-seq, and RNA fragmentation ([Table 1](#tbl1){ref-type="table"}). To limit the influence of confounding factors in our analyses, we selected datasets for a single species only (mouse) and mapped reads to non-overlapping RefSeq transcripts without splice variants as it was done before ([@bib30]); overlapping genes and genes with multiple isoform annotations would potentially give rise to more complex coverage shapes that are independent from the protocol-specific effects we want to study.

In order to effectively visualize coverage and define global shapes present within each dataset, we ordered transcripts according to their lengths and color-coded read densities in 20 bins along the transcripts after length normalization ([Figure 1](#fig1){ref-type="fig"}C). This highlights the "noisiness" of the data due to the various bias sources but also confirms some previous observations: poly-A primed libraries tend to exhibit a 3′ bias ([@bib33]), SMART protocols produce reasonable coverage even for longer transcripts ([@bib38]), and the profiles depend on transcript length ([@bib5]) ([Figure 1](#fig1){ref-type="fig"}C). Random priming yields more uniform, yet 5′-biased coverage, as previously reported ([@bib33]) ([Figure 1](#fig1){ref-type="fig"}C). Virtually all datasets feature underrepresented regions close to transcript ends, presumably due to inefficient fragmentation as discussed above. We include a plot for CEL-seq data, which confirms selection of 3′ fragments ([Figure 1](#fig1){ref-type="fig"}C).

Several features of the data have been noted before ([@bib1], [@bib38]) but warrant more discussion and analysis: the 3′ bias in the SMART and poly-A-tagging datasets tends to worsen with increasing transcript lengths, whereas the coverage of shorter transcripts is more uniform and even 5′ biased in some cases. In addition, bimodality in the coverage (high read densities at 5′ and 3′ ends, low density in the centers of transcripts) appears for transcripts of intermediate and/or long lengths (\> ∼3 kb) in most SMART-seq datasets ([Figure 1](#fig1){ref-type="fig"}C; more datasets are shown in [Figure S1](#mmc1){ref-type="supplementary-material"}). It is also noteworthy how similar these aspects are among poly-A-tagging and SMART protocols, given the differences between these. Although the graininess of the data is affected by the amount of starting material/PCR cycles, the bias shapes appear independent of this (Bhargava datasets, [Figure S1](#mmc1){ref-type="supplementary-material"}). The only protocol without strong systematic bias (aside from underrepresented ends) is RNA fragmentation ([Figure S1](#mmc1){ref-type="supplementary-material"}).

As a first step toward understanding these phenomena, we asked whether they could be recapitulated by simplified models ([Figure 1](#fig1){ref-type="fig"}D). To this end, we defined the expected and assumed differences among the protocols, including their possible limitations, in a set of five abstracted and simplified models (these are summarized graphically in [Figure 1](#fig1){ref-type="fig"}D). We label these from "A" to "E," which roughly increase in complexity, starting with the idealistic scenario of full-length syntheses for both first- and second-strand "A." This would be compatible with an optimally functioning SMART protocol, free from any coverage bias, similar also to earlier assumptions of uniform coverage of RNA-seq data (using the measure of fragments per kilobase per million total fragments \[FPKM\]; see below). Models B and C correspond to successful full-length selection for fragments containing either the 3′ or 5′ transcript end, respectively (i.e., by PCR with 3′ flanking primers or full-length SMART on 5′ end, respectively). We consider models that abstract non-full-length poly-A tagging (model D) and random priming (model E) and also the possibility of a combination of these simpler models ([Figure 1](#fig1){ref-type="fig"}D). The models are discussed in greater conceptual detail below.

RNA-seq library preparation can be understood as a stochastic process, where steps in the protocol depend on preceding ones and are associated with varying degrees of randomness. A convenient and very intuitive way to model this is by using conditional probabilities ([Box 1](#tbox1){ref-type="boxed-text"}). For instance, given that first-strand synthesis starts at position *s*~*1*~ along the transcript, it might end at position *e*~*1*~ with probability *P*(*e*~1~ \| *s*~1~). The starting position of the second-strand synthesis, *s*~2~, would then depend on this, giving *P*(*s*~2~ \| *e*~1~), and so forth ([Figure 1](#fig1){ref-type="fig"}A, see [Method Details](#sec4.4){ref-type="sec"} for details). We use this approach to capture the various aspects of the protocols with the aim of quantitatively and formally understanding their expected influence on shaping the distributions of sequencing read starting positions (mathematical models can be found in the Models section of [Method Details](#sec4.4){ref-type="sec"}). While our framework is very flexible and allows us to easily include several different factors, we focused on the effects of enzyme reactions during cDNA conversion as captured by our minimal models A to E ([Figure 1](#fig1){ref-type="fig"}D). We thus do not consider sequence-specific biases and the lengths of primers. We also exclude factors that are expected to cause overall loss with regards to the starting material but do not introduce bias. Failed poly-A tail priming, for instance, will probably affect different transcripts with roughly equal probability, so we do not consider it in our analysis. In contrast, usage of random first-strand primers plausibly will favor cDNA conversion of longer transcripts, as the chances of binding are higher.

Depending on the protocol, the start and endpoints of enzymatic syntheses during cDNA conversion are determined not only by priming positions but also by the enzymes' average synthesis lengths, their "processivities." The enzymes' processivities are in general likely to depend on several parameters, such as temperature or nucleotide concentration, and could reflect eventual stops in the synthesis process or physical detachments of the enzyme from its template or both. The processivity of the reverse transcription is influenced by mRNA secondary structure as well, which again depends on other factors, including sequence and temperature ([@bib24]). In total, cDNA strand synthesis length is most commonly assumed to roughly follow geometric/exponential distributions ([@bib4], [@bib51]). We adapt this for our model and assume *P*(*e*~1~ \| *s*~1~) and *P*(*e*~2~ \| *s*~2~) follow exponential distributions, taking also account of possible full-length synthesis (see [Figure S2](#mmc1){ref-type="supplementary-material"} and [STAR Methods](#sec4){ref-type="sec"}). The distributions are subject to parameters *θ*~1~ and *θ*~2~, which are inversely proportional to the processivities of the first- and second-strand synthesis. Finally, we include terms in our model to account for reduced fragmentation efficiency at the ends of the double-stranded cDNAs in the library. This has the form of a step change of sequencing probability as given by parameter *d* over distance *h* from either end.

Based on these considerations, we derived expressions for the expected coverage of our models A to E as functions of transcript length *l*. These have the forms of various combinations of exponential terms and are of moderate complexity ([Table 2](#tbl2){ref-type="table"}, shown without *d*, *h* terms for clarity). It is of note that the expression for model A and its notion of "ideal" SMART can be interpreted in two ways; either full-length syntheses are achieved by very high processivities (giving essentially *θ*~1~ = *θ*~2~ = 0), or full-length cDNA is enriched over incomplete products (e.g., by PCR and/or the SMART mechanism), allowing for higher *θ*~1~ and *θ*~2~, but implying exponentially decreasing sequencing efficiency with increasing mRNA length.

Models A, B, and C restrict the global coverage shapes that can be expected to a straight line or simple exponential decreases from either side, respectively, for all lengths ([Figure 2](#fig2){ref-type="fig"}A). However, the coverage obtained with model "D" under realistic parameter settings resembles the experimental SMART datasets, capturing the transition from 5′ to bimodal to 3′ bias ([Figure 2](#fig2){ref-type="fig"}A). Model D also predicts lower densities for the 5′ edges compared to the 3′ edges throughout, in the regions where fragmentation efficiency is reduced ([Figure 2](#fig2){ref-type="fig"}A). This too appears to mirror the experimental data for all relevant protocols. Using the same parameter settings, we obtain equally promising shapes for model E, which resembles the 5′-biased random-priming data it is designed to explain ([Figure 1](#fig1){ref-type="fig"}C). The overall characteristics of the bias shapes are conserved if the skewed distribution of natural transcript lengths is replaced with a linear function ([Figure S3](#mmc1){ref-type="supplementary-material"}a).

We proceeded to test fits of our models to the actual datasets and infer parameters using a Markov Chain Monte Carlo (MCMC) approach ([STAR Methods](#sec4){ref-type="sec"}). As the coverage in models A and C does not depend on all the parameters, in these cases a subset of parameters are inferred. We compare the quality of the fits we obtain for all models based on their likelihoods ([STAR Methods](#sec4){ref-type="sec"}), which reveals that models B and D provide best fits for poly-A-tagging and SMART datasets ([Figure S3](#mmc1){ref-type="supplementary-material"}b). Model D, in particular, captures well the changing coverage shapes with increasing transcript lengths ([Figure 2](#fig2){ref-type="fig"}B). Given these findings, we presumed that second-strand priming and partial PCR selection of both, poly-A-tagging and SMART protocols is captured best by a combination of models B and D, which indeed yields the best fits ([Figures S3](#mmc1){ref-type="supplementary-material"}b and [2](#fig2){ref-type="fig"}B). The parameter values we obtained for the combined model suggest that the average synthesis lengths for the first- and second-strands are about 5--10 and 1--3 kb, respectively ([Figures 2](#fig2){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}), which agrees with estimates from the literature ([@bib24]). The parameterized models capture behavior observed in in vivo datasets, suggesting that the assumptions made during modeling are reasonably conservative. For example, increasing the number of PCR cycles used in the SMART protocol should result in an increase in the proportion of the (full-length second-strand) model B over D, as parameterized by parameter *α* ([Method Details](#sec4.4){ref-type="sec"}). The Bhargava dataset allows testing this as it includes samples subjected to different numbers of PCR cycles. *α* indeed increases significantly (p \< 10^−9^, one-sided Mann-Whitney U test) with higher numbers of PCR cycles for two different biological samples (Activin A treated \[AA\]; serum-free media \[SFM\]; [Figure 2](#fig2){ref-type="fig"}D).

Our parameterized models allow us to test the common assumptions about how scRNA-seq and RNA-seq protocols work. Model A and model C clearly perform worse as these restrict the coverages to patterns that are not observed in the data, which is reflected in the goodness-of-fit statistics ([Figure S3](#mmc1){ref-type="supplementary-material"}b). This suggests that the common assumptions regarding SMART protocols are too optimistic. For example, second-strand synthesis appears to frequently start within transcripts, not at ends only, and selection for complete second-strands is imperfect, which explains the similarities between poly-A-tagging and SMART protocols. A similar observation termed "strand invasion" was made for the nanoCAGE technique recently, where it was found that the second-strand primer ("template switching oligo") can bind the first-strand internally at complementary sequences ([@bib47]). As expected, model E fits well the random-priming datasets, but not the poly-A-tagging and SMART datasets ([Figures 2](#fig2){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}b; see [Figure S5](#mmc1){ref-type="supplementary-material"} for parameter estimates of the remaining models).

Altered Incubation Temperature and Model-Driven Improvement to RNA-Seq Protocols {#sec2.1}
--------------------------------------------------------------------------------

While the goodness of our fits and the underlying logic suggest our modeling approach is valid, we sought further experimental confirmation. To this end, we prepared RNA-seq samples designed to specifically perturb single parameter values only and sequenced them on an Illumina MiSeq sequencing machine. We focused on incubation temperature for enzyme reactions because it is both experimentally accessible and interpretable: we reckoned that it should affect polymerase processivity. We prepared libraries using lowered temperatures during reverse transcription (25°C instead of the standard 42°C) and/or second-strand synthesis (42°C instead of the standard 72°C); protocols were based on and generated by SMART-seq or Quartz-seq and began with different starting RNAs (poly-A+, total RNA, single cell; see [Table S1](#mmc1){ref-type="supplementary-material"} for a list of all samples).

If the notions underlying our modeling approach are correct, the changed temperatures should change the corresponding parameter estimates while the remaining parameter estimates should remain the same. The parameter estimates we obtained confirm this reasoning; lowering first-strand temperature changes *θ*~1~ estimates without affecting *θ*~2~ significantly, and vice versa if second-strand temperature is changed ([Figures 3](#fig3){ref-type="fig"}A and 3B; examples for coverage plots [Figure S6](#mmc1){ref-type="supplementary-material"}). An exception is the significantly different *θ*~1~ estimate upon changing second-strand temperature with first-strand synthesis at 25°C; however, in this case, the median is very close.

We note that estimation of *θ*~2~ for SMART-seq is less precise, as the PCR step with flanking primers means that the original second-strand contributes substantially less to the shape of the coverage (compare this to model A, "ideal SMART-seq," which would not even allow estimation of *θ*~1~, as discussed above), thus obscuring the temperature-related differences. For this reason, we excluded SMART-seq samples from the plot for *θ*~2~ in [Figure 3](#fig3){ref-type="fig"}B (they are shown as [Figure S7](#mmc1){ref-type="supplementary-material"}a) and instead add SMART-seq samples where we omitted the PCR step ([Figures 3](#fig3){ref-type="fig"}A and 3B), which yields similar results as the other protocols.

This analysis also revealed an unexpected feature of cDNA synthesis: lowering temperatures appears to *increase* processivities of the enzymes ([Figures 3](#fig3){ref-type="fig"}A and 3B). This observation suggests that lowering incubation temperatures should improve the yield of RNA-seq protocols. We therefore measured by Qubit the absolute amount of cDNA produced from the same starting amounts of mRNA and synthesis reactions carried out at the temperatures described above. We observed significantly (p ≤ 0.001, one-sided t test) increased cDNA synthesis at lower temperatures, with an optimum yield upon lowering both temperatures ([Figure 3](#fig3){ref-type="fig"}C). To further investigate the increase in processivity, we turned to RNA-seq again. We prepared RNA-seq samples from the same RNA, aliquoted the samples for each temperature, and sequenced these on the same lane using indexed primers. Increased processivities should increase the proportion of longer mRNAs within the samples. We thus compared the relative representation by sequencing reads of transcripts of different lengths normalized to corresponding read numbers at the standard incubation temperatures. Indeed, we observe significantly increased representation of longer transcripts ([Figure 3](#fig3){ref-type="fig"}D); this is in accordance with the Qubit measurement and suggests that polymerase processivity increases at low temperatures. We further compared the numbers of genes detected and the overall numbers of sequencing reads we obtained for transcripts and for spike-in probes, which we had added to a subset of starting RNAs for our RNA-seq samples. This confirms increased yields upon reduced temperatures ([Figures 3](#fig3){ref-type="fig"}E--3G). Accordingly, RNA-seq also became more sensitive: we were able to detect lower concentrations of the spike-in probes ([Figure 3](#fig3){ref-type="fig"}H). Notably, reducing the incubation temperatures does not appear to increase local bias. The coverage heatmaps do not exhibit obvious visual differences regarding their "noisiness" ([Figure S6](#mmc1){ref-type="supplementary-material"}), and quantifying this rather suggests improved coverage uniformity upon reduced incubation temperatures ([Figure S7](#mmc1){ref-type="supplementary-material"}b). These findings show an improved RNA-seq performance at lower temperatures and illustrate how insights generated by our framework can be exploited to optimize protocols.

Our framework can also improve analysis of existing data. For example, accurate quantitation of mRNA expression necessitates a thorough understanding of the expected numbers of sequencing reads for different types of transcripts. The simplest notion of linear scaling with transcript length is embodied in the classical RNA-seq FPKM measure, which is now generally understood to be an oversimplification but still widely used. Several approaches to take account of non-uniform read distributions along transcripts have been published and are included in common RNA-seq analysis software, such as CuffLinks ([@bib40], [@bib48]) or RNA-Seq by Expectation Maximization (RSEM; [@bib27]). These approaches focus mostly on the correction of biases *within* transcripts to yield corrected FPKM. Thus, while approaches like these improve isoform quantitation, they do not account for the non-linear scaling of expected read numbers *across* transcripts of different lengths (see Note - previous approaches to correct coverage bias in [Method Details](#sec4.4){ref-type="sec"}).

Using our probabilistic framework, we can predict the expected sequencing read numbers for any transcript length, tailored to the library preparation protocol that was used and with parameters inferred from the fit to the corresponding RNA-seq dataset. The expected read numbers are proportional to the areas under the coverage curves that our models predict. Normalizing read numbers of transcripts by the area under the coverage curves for their corresponding length will thus remove the bias and provide a more precise abundance estimate ([Method Details](#sec4.4){ref-type="sec"}). Plotting transcript lengths versus these abundance estimates reveals that model E approaches a linear measure equivalent to FPKM (and model A with *θ*~1~ = *θ*~2~ = 0) for longer transcripts, while the other models reach plateaus at roughly 4 kb using a single parameter set close to inferred ones ([Figure 4](#fig4){ref-type="fig"}A). This highlights protocol-specific gene length dependent sensitivity, since the areas our models predict estimate the relative mass of an mRNA that is converted to double-stranded cDNA, if non-enzyme-induced losses, such as incomplete primer binding, are ignored. Increasing transcript length beyond ∼4 kb does not increase sensitivity for non-random priming protocols.

The length scaling of models B--D also means that FPKM-based measures strongly underestimate long transcripts prepared with SMART or poly-A-tagging datasets due to enzyme drop-offs. Benchmarking this prediction based on correlation with standard qPCR or microarray data is not useful per se as the latter are mostly subject to the same protocol-derived biases we are describing. However, the Wold (SMART) dataset contains a set of spike-in RNA probes of different lengths at known relative concentrations ([@bib23]). The longest of these probes is still comparatively short, at 2,022 bases. Yet, plotting normalized (by nominal probe concentration) and standardized (subtraction of mean and division by SD) Cufflinks or RSEM abundance estimates versus probe length reveals negative trends, confirming our prediction of length-dependent underestimation ([Figure 4](#fig4){ref-type="fig"}B). Applying our abundance estimates derived from the fits to the model B&D almost completely eliminates this trend ([Figure 4](#fig4){ref-type="fig"}B).

To extend this analysis to greater transcript lengths, we randomly selected 12 genes ([Table S2](#mmc1){ref-type="supplementary-material"}) covering mRNA lengths from ∼2 to ∼22 kb with intermediate read counts from our RNA-seq samples ([Table S1](#mmc1){ref-type="supplementary-material"}; we included samples corresponding to different incubation temperatures and pooled these after quantifying them separately to maximize the data we were using; the different temperatures are thus not relevant in this analysis). Quantifying their expression levels based on Cufflinks, RSEM, or our Model D fits yields similar results as above; Cufflinks and RSEM estimates exhibit anti-correlation with mRNA length, which is much less pronounced with our model ([Figure 4](#fig4){ref-type="fig"}C).

Next, we experimentally test the actual expression levels of the selected transcripts and how they related to their lengths. To this end, we performed qPCR on the same RNA samples, but using primers pairs close (\< ∼200 bases) to the 3′ ends of the mRNAs in order to strongly limit the effects of enzyme conversion. Indeed, the results demonstrate better agreement with our models than established methods regarding the measured mRNA abundances versus their lengths ([Figure 4](#fig4){ref-type="fig"}C). Furthermore, correlation between the qPCR results and RNA-seq expression estimates is higher for our model than for Cufflinks or RSEM ([Figure S8](#mmc1){ref-type="supplementary-material"}a). Notably, transcript expression levels, in particular at the low range, still appeared moderately anti-correlated with length after correction, even with the RNA fragmentation ([Figure S8](#mmc1){ref-type="supplementary-material"}b) and qPCR data ([Figure 4](#fig4){ref-type="fig"}C), which support the notion that, biologically, longer genes are on average expressed at a lower level.

Finally, we wanted to test whether the improved, protocol-specific mRNA quantification of our method can reduce library-preparation-induced differences among biological datasets. We have included in our study four datasets for the same cell type (Th2 cells) but using different library preparation protocols. If our method provides more reliable estimates for expression levels, its application should increase correlations among the datasets. We performed individual model fits tailored to the library preparation protocols used in each case and calculated correlations among the datasets with regards to expression levels of all genes. Our models indeed yield higher correlations in most cases compared to Cufflinks- and RSEM-based expression quantification, even though our models do not even take account of sequence-specific, local bias ([Figure 4](#fig4){ref-type="fig"}D).

Discussion {#sec3}
==========

We present here a mathematical framework to model library preparation protocols, which addresses several important issues with regards to RNA-seq and, specifically, scRNA-seq. Our approach offers a unified treatment of coverage bias, inference of reaction mechanisms, quantification, sensitivity, and design guidance for library preparation protocols. It can be easily adapted to protocols not covered here and to future developments.

Protocols with limited bias, such as those using RNA fragmentation, will profit from our approach as well; sample preparation of these can potentially be improved based on general insights generated with our framework, such as the cDNA-yield increasing effects of altered incubation temperatures. Furthermore, our models can be easily extended to take account of RNA degradation (see Note - previous approaches to correct coverage bias in [Method Details](#sec4.4){ref-type="sec"}); although this is not implemented yet, our approach of modeling the logics of sample preparation permits inclusion of RNA degradation mechanisms in our models and thus potentially allows analysis and/or correction of their effects. It is also straightforward to integrate and combine our bias correction with previous methods focused on other issues such as the sequence-specific bias; our abundance estimates can be simply included as correction factors, e.g., in the likelihood functions for read numbers of individual isoforms, while the model fitting and thus learning of parameters can be performed on a reduced gene set without overlapping genes.

A first application of our modeling framework suggests an incomplete understanding of the mechanisms underlying SMART protocols and yields processivities of enzymes during library preparation. Notably, our approach presents a novel alternative to processivity measurements by radioactive footprint assays ([@bib2]). An interesting extension of this aspect of our work would be to explore alternatives to the exponential enzyme drop-offs we assumed. Usage of enzymes under saturating conditions might feasibly result in strands that correspond to concatenates of several individual polymerization processes, requiring more complex models ([Method Details](#sec4.4){ref-type="sec"}).

Another prediction from our study is the substantial underestimation of expression levels of long transcripts with poly-A priming and SMART protocols if read numbers are assumed to scale linearly versus length. This is due to the small fraction of a long mRNA that becomes double-stranded cDNA and also implies under-exploitation of the starting material, thus forgoing a potentially higher sensitivity with current scRNA-seq protocols. Inclusion of spike-in probes that are longer than the current standard (\< 2 kb) might be valuable for RNA-seq experiments in general to allow for better monitoring of this effect. This might require a different probe production technique from the commonly employed in vitro transcription, which becomes ineffective for long templates.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse FITC CD5+eBioscience11-0051-81; RRID: [AB_464907](nif-antibody:AB_464907){#intref0010}**Chemicals, Peptides, and Recombinant Proteins**Smart MMLV Reverse TranscriptaseClontechCat\#639524Kappa TaqKappaBiosystemsCat\#07958447001SMARTer cDNA Synthesis KitClontechCat\#634925RNase Inhibitor, MurineNew England BiolabsCat\#M0314Control Mouse Liver Total RNAClontechCat\#636603Sensimix SYBR No-RoxBioLineCat\#QT650-05RNase HThermoFisherCat\#EN0201SuperScript IIThermoFisherCat\#18064014dNTPs (Individual)New England BiolabsPart\#N0446SLympholyte-M Cell Separation MediaCedarlane labsCode\#CL5030Exonuclease INew England BiolabsPart\#M0293Deoxynucleotide (dNTP) Solution SetNew England BiolabsPart\#N0446STerminal deoxynucleotidyl transferase (TdT)PromegaCat\#M1871NP-40ThermoFisherCat\#28324Agencourt Ampure XP BeadsBeckman CoulterPart\#A63881polyA Spin mRNA Isolation KitNew England BiolabsCat\#S1560STRIzol ReagentThermofisherCat\#15596018NEB next qPCR quantification kitNew England BiolabsCat\#E7630L**Critical Commercial Assays**Nextera XT DNA Library Preparation kitIlluminaCat\#FC-131-1024Nextera XT index kitIlluminaCat\#FC-131-1001Miseq Reagent kit v3 (150 cycle)IlluminaCat\#MS-102-3001Qubit Fluorometric QuantitationThermofisherCat\#Q32866Agilent 2100 high sensitivity kitAgilent TechnologiesG2939AA**Deposited Data**Data Files for RNA sequencingThis PaperGEO: [GSE84785](ncbi-geo:GSE84785){#intref0015}For previously published datasets used in this study see [Table 1](#tbl1){ref-type="table"}VariousN/A**Experimental Models: Organisms/Strains**Mouse B6CBF1 wildtypeRodent Facility, University of WarwickN/A**Sequence-Based Reagents**For qPCR primers see [Table S2](#mmc1){ref-type="supplementary-material"}This PaperN/ASmart-seq 2 Template Switching Oligonucleotide AAGCAGTGGTATCAACGCAGAGTACrGrG+G[@bib36]N/AQuartz-seq RT primer (WTA) TATAGAATTCGCGGCCGCTCGCGATAATACGACTCACTATAGGGCGTTTTTTTTTTTTTTTTTTTTTTTT[@bib41]N/AQuartz-seq Tagging primer TATAGAATTCGCGGCCGCTCGCGATTTTTTTTTTTTTTTTTTTTTTTT[@bib41]N/AQuartz-seq suppression PCR primer /5AmMC6/GTATAGAATTCGCGGCCGCTCGCGAT[@bib41]N/AERCC Spike-in mixAmbion (Thermofisher)Cat\#4456740**Software and Algorithms**Mathematica (v10.4)Wolfram Research, Inc.<http://www.wolfram.com/education/>Bowtie (v1.0.0)[@bib26]<http://bowtie-bio.sourceforge.net/index.shtml>MATLAB MCMC toolbox[@bib11][http://helios.fmi.fi/∼lainema/mcmc](http://helios.fmi.fi/%7Elainema/mcmc){#intref0035}MATLAB and Statistics ToolboxThe MathWorks, Inc.<http://www.mathworks.com/includes_content/domainRedirect/domainRedirect.html?uri=http%3A%2F%2Fuk.mathworks.com%2F>Cufflinks (v2.2.1)[@bib48]<http://cole-trapnell-lab.github.io/cufflinks/>SRA ToolkitNCBI<http://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi>RSEM[@bib27]<http://deweylab.biostat.wisc.edu/rsem/>*qpcR R* library[@bib39]<https://cran.r-project.org/web/packages/qpcR/index.html>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for reagents may be directed to Lead Contact Daniel Hebenstreit (<D.Hebenstreit@warwick.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mice {#sec4.3.1}

All projects involving animals, including studies not subject to home office licensing are scrutinised and approved by AWERB, established with Home Office guidance and RSPCA/LASA guiding principles on good practice for local ethical review processes. The AWERB ensures that in all cases staff and students are trained and appropriately experienced and that the potential benefits of the research outweigh the effects on the animals concerned while being committed to the promotion of 3Rs (reduction, refinement and replacement). Wild-type B6CBF1 mice were used for splenocyte isolation from spleen. Total mouse RNA used in some experiments was purchased from Clontech.

Method Details {#sec4.4}
--------------

### RNA isolation and preparation {#sec4.4.1}

Starting RNA was either "mouse liver control RNA" (Clontech), or was prepared from murine lymphocytes that were isolated from a B6CBF1 mouse spleen by homogenization through a cell strainer in DMEM-10 media, followed by centrifugation through Lympholyte Ficoll (Cedarlane). For single cell preparations, lymphocytes were additionally stained with anti-CD5 FITC antibody and sorted using a FACS aria fusion (BD Bioscience) into lysis buffer immediately before first-strand synthesis (see below). Otherwise, total RNA was extracted from the lymphocyte suspension using 1 mL Trizol (Ambion) and isolated with 500 μL chloroform before being ethanol precipitated. This was followed by poly-A purification for a selection of samples ([Table S1](#mmc1){ref-type="supplementary-material"}) using the polyA Spin mRNA isolation kit (NEB) following the manufacturer's instructions. ERCC spike-in probes were added to a subset of samples in the following way. 0.2 μL of a 1:10 dilution of ERCC spike-ins (Ambion) were added to 1 μL of 1μg/μL total RNA, before dilution to 100 pg/μL for low input samples, while 1 μl of a 1:10 dilution were included with the samples containing 100 ng of poly-A+ RNA ([Table S1](#mmc1){ref-type="supplementary-material"}). The RNA was then divided into two equal samples for the different first-strand incubation temperatures.

### SMART-seq, SMART-seq2 {#sec4.4.2}

First-strand synthesis was performed in two separate reactions using the SMART cDNA synthesis kit (Takara Clontech), with different temperatures either 25°C or 42°C but otherwise following the manufacturers' instructions. In brief, 1 μg total RNA or 100 ng poly-A+ RNA from murine lymphocytes or liver in 3.5 μL was mixed with 1 μL of anchored 12 μM Oligo(dT) (3′ SMART CDS Primer II A) and denatured at 72°C for 3 min in a thermocycler with a heated lid, before the temperature was dropped to the desired first-strand synthesis temperature. The following were then added for a 60 min incubation: 1 μL 10 mM dNTP mix, 1 μL MMLV SMARTscribe reverse transcriptase (Takara Clontech), 0.25 μL RNase inhibitor, 2 μL 5X smart scribe first-strand buffer, 0.25 μL 100 mM DTT, and 1 μL of 12 μM template switching oligo (SMARTer II A Oligonucleotide).

SMART-seq2 was carried out as described in Picelli et al. ([@bib36]), with either isolated, lysed cells or 10 pg of total input RNA. In brief, a single lysed CD5+ cell or 10 pg of total RNA (0.1 μL of 100 pg/μL RNA) was mixed with 0.3 μL of anchored 12 μM Oligo(dT) (3′ SMART CDS Primer II A) and 0.3 μL of 10 mM dNTPs before being denatured at 72°C as in SMART-seq "1" as above. Upon reaching the desired first-strand synthesis temperature, 0.5 ul 5X first-strand buffer, 0.5 μL betaine, 0.003 μl MgCl2, 0.06 μl DTT (100 mM stock), 0.25 μl LNA template switching 5′ Oligo, 0.06 μl RNase inhibitor, and 0.25 μl reverse transcriptase (100 u/μL) were added. First-strand synthesis was then carried out at either 25°C or 42°C including the SMART-seq2 temperature cycling as in the below table where xx is the first-strand synthesis temperature.Single cell Smart-seq2 first strand where **xx** is the chosen first-strand synthesis temperature of 25 or 42CycleTemperature (°C)Time1xx90 min2 to 11502 min2 to 11xx2 min12xx15 min134Infinite hold

After first-strand synthesis, each sample was again divided into two equal samples for the different second-strand incubation temperatures. Second-strand synthesis was performed with TAQ polymerase (KAPPA) in "Buffer A" tris-ammonium sulfate based buffer with 1.5 mM MgCl~2~ and in the presence of 200 μM dNTPs with 1 μL of 12 μM 5′ PCR primer ('5-AAGCAGTGGTATCAACGCAGAGT-3′) to prime the second-strand synthesis. Samples were incubated for 20 min at either 72°C or 42°C, followed by PCR for a subset of the SMART-seq samples. PCR was included for all SMART-seq2 samples as follows where xx is the second-strand synthesis temperature:SMART-seq (with PCR) and Smart-seq2 PCR conditions where **xx** is the chosen second-strand synthesis temperature of 42 or 72CycleTemperature (°C)Time1983 min2 to 199820 s2 to 196815 s2 to 19xx6 min20xx5 min214Infinite hold

Qubit analysis ensured that 1 ng of dual stranded input cDNA for the "tagmentation" reaction using Nextera XT (Illumina) carried out following the manufacturer's instructions including a 12 cycle PCR, at which point molecular barcodes were added identifying the reverse transcription conditions. Ampure XP beads were used to purify the reaction products before quantitation and pooling.

Agilent 2100 high sensitivity kit was used to determine the average fragment size, while quantification was done with a Qubit high sensitivity kit, allowing the libraries to be diluted to a final concentration of 4 nM and pooled, this was then confirmed using the NEB next qPCR quantification kit (NEB). The reactions were then denatured with 0.1 N NaOH and 20 pmol sequenced on Illumina MiSeq using reagents kits v3 in a 75 bp paired-end run. The data were deposited at GEO (<http://www.ncbi.nlm.nih.gov/geo/>, accession number GEO: [GSE84785](ncbi-geo:GSE84785){#intref0075}).

### Quartz-seq {#sec4.4.3}

Quartz-seq was carried out on 100 ng poly-A purified RNA as previously described ([@bib41]) with minor modifications. In brief, 100 ng of poly-A purified RNA in 3.5 μL was mixed with 1 μL of 10 μM RT Primer (TATAGAATTCGCGGCCGCTCGCGATAATACGACTCACTATAGGGCG\[T\]~24~) and denatured at 70°C for 90 s in a thermocycler with a heated lid. The following was then added to each sample at 4°C: 1 μL10 mM dNTP mix, 1 μL MMLV SMARTscribe reverse transcriptase (Takara Clontech), 0.25 μL RNase inhibitor, 2 μL 5X smart scribe first-strand buffer, 0.25 μL 100 mM DTT and 1 μL nuclease free water. First-strand synthesis was then carried out in a thermocycler at either 25°C or 42°C (xx) as below:Quartz-seq first-strand where **xx** is the chosen first-strand synthesis temperature of 25 or 42CycleTemperature (°C)Time14To begin2355 min3xx20 min47010 min54Infinite hold

Following first-strand synthesis, the primers were removed using Exonuclease I digestion in Kappa PCR "Buffer A" tris-ammonium sulfate based buffer with 1.5 mM MgCl~2~. Poly(A) tailing of the single stranded cDNA was then carried out using TdT in the presence of 0.15 mM dATP and Rnase H for 50 s. Second-strand synthesis was carried out for 20 min at either 72°C or 42°C using Kappa Taq as previously. PCR enrichment was carried out using TAQ polymerase (KAPPA) in "Buffer A" tris-ammonium sulfate based buffer with 1.5 mM MgCl2 and in the presence of 200 μM dNTPs with 1 μL of 10 μM PCR primer (NH~2~)-GTATAGAATTCGCGGCCGCTCGCGAT, with the following PCR program:Quartz-seq enrichment PCR where **xx** is the chosen second-strand synthesis temperature of 42 or 72CycleTemperature (°C)Time168To begin2-189810 s2-186515 s2-18xx5 min19xx5 min204Infinite hold

### qPCR & RNA-seq length correlation analysis {#sec4.4.4}

Two poly-A+ RNA samples corresponding to Smartseq.noPCR.a.ng and Smartseq.noPCR.d.ng ([Table S1](#mmc1){ref-type="supplementary-material"}) were subjected to first-strand synthesis as outlined previously, with the exception that the template switching oligo (TSO) was not included. SensiMix SYBR No-ROX kit (Bioline) was used for qPCR following the manufacturer's protocol, with the exception of a reduced volume to 10 μl. PCR primers were designed to be located close to the 3′ ends of twelve transcripts covering a range of lengths from ∼2 to ∼22 kb ([Table S2](#mmc1){ref-type="supplementary-material"}). We designed multiple alternative reverse primers for some genes to test precision of the qPCR ([Table S2](#mmc1){ref-type="supplementary-material"}). These gave very similar results which were averaged for analysis. The reactions were carried out on a QIAGEN Rotorgene-Q 5-plex model, running software v2.1.0, using conditions as shown below:qPCR conditionsCycleTemperature (°C)Time19510 min2-459515 s2-456015 s2-457215 s

The transcripts' expression levels were calculated as 2^-*Ct*^, where *Ct* was calculated with the *qpcR R* library, and were z-transformed separately for the two RNA samples. The pooled expression levels were plotted against the corresponding transcript lengths and a linear model was fitted with the *R* function *lm*().

In parallel, we calculated expression levels for the RNA-seq samples corresponding to the same RNA starting preparations (Smartseq.noPCR.a.ng and Smartseq.noPCR.d.ng; all temperature variations were used; [Table S1](#mmc1){ref-type="supplementary-material"}). We analyzed the samples with CuffLinks, RSEM, or fitted our Model D as described below. We averaged expression levels for all temperatures variations of the same starting RNA, and processed the data further in the same way as the qPCR data.

### Data processing {#sec4.4.5}

Datasets (see [Table 1](#tbl1){ref-type="table"} for accession codes) were downloaded from GEO (<http://www.ncbi.nlm.nih.gov/geo/>) or ENCODE (<https://www.encodeproject.org/>). SRA format files were converted to FASTQ format files using the fastq-dump program from the SRA Toolkit (<https://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?view=toolkit_doc>). We downloaded RefSeq gene annotations for the mouse genome (mm10) from UCSC Genome Browser (<https://genome.ucsc.edu/>). We then used custom Perl scripts to remove all entries that overlapped each other or corresponded to multiple isoforms of a gene. The mRNA sequences for the remaining entries were downloaded from UCSC Genome Browser and were clipped by any 3′ stretches of poly-A. In addition, we downloaded a FASTA file for the ERCC-mix1 spike-in controls from <https://www.encodeproject.org/datasets/ENCSR156CIL/>. Both sets of sequences were used to generate indices for Bowtie 1.0.0 ([@bib26]). All datasets were then mapped to the appropriate indices with Bowtie, using option '-m 1'. The starting positions of reads were extracted from the mapping output files and were collected as lists for each transcript. Names, lengths, and read position lists of each transcript were saved into files, which were used as input for the parameter estimations.

Datasets produced in this study were processed as described above, with 'NR\_' transcripts removed from the annotation file for most analyses due to an outlying ribosomal RNA that was present also in all poly-A+ samples. Unique read mappings were ∼20 to 50% for poly-A+ RNA and ∼2 to 5% for total RNA. Please note that our parameter estimations do not require large read numbers; we therefore aimed for ∼0.1M to ∼1M reads per individual sample ([Table S1](#mmc1){ref-type="supplementary-material"}).

To calculate FPKM using the bias correction approach by Roberts et al. ([@bib40]), we downloaded and ran CuffLinks 2.2.1 (<http://cole-trapnell-lab.github.io/cufflinks/cuffdiff/>) ([@bib48]). We supplied it with a GTF and a FASTA file prepared from our transcript sequences, using options *-G* and *-b*, respectively.

To calculate FPKM using the RSEM bias correction approach ([@bib27]), we downloaded RSEM 1.2.22 software (<http://deweylab.biostat.wisc.edu/rsem/>) and used the function *rsem-prepare-reference* to produce an RSEM index for our transcript sequences. We then ran *rsem-calculate-expression* using options *--sam*, *--estimate-rspd* and *--no-bam-output,* and in addition --*paired-end* for the Mahata dataset.

FPKM for spike-in probes in newly generated RNA-seq samples were calculated using the standard formula (10^9^ × reads × probe-length^-1^ × total-reads^-1^), where total reads were all reads mapping to the spike-in probes.

The coverage plots were generated in *Mathematica* 10 using the function *ArrayPlot* after calculating the densities of read starting positions in 20 equally sized bins along the transcript lengths. The *ColorFunction* in *ArrayPlot* was set to *ColorData*\["*SunsetColors*"\]\[1 - 10 \#\] &. The same binned data were used to compare coverage uniformity in the following way; RNA-seq samples prepared at standard temperatures and the corresponding low-temperature samples were compared in terms of the numbers of detected genes. All genes of the sample with the lower number were used for further processing. A random sample of the same number of genes was selected from the other sample. This was done in order to process equal numbers of genes for the two samples. We then calculated the statistical entropy for the binned data of all genes in both samples, since entropy becomes maximal for uniform distributions. We then calculated the medians of these distributions and their ratio regarding high- and low-temperature samples.

### Parameter estimation {#sec4.4.6}

We used a Bayesian Markov Chain Monte Carlo (MCMC) Framework to fit the RNA-seq data and infer parameters of each model. The number of reads processed for a transcript was limited to 100, to reduce computational time. We confirmed including more data did not affect our parameter estimates. We further used similar read numbers for different ranges of gene lengths to obtain an unbiased estimate across all transcript lengths. We used likelihood ratios to test the goodness-of-fits of the models. Inference was performed using the MATLAB MCMC toolbox ([http://helios.fmi.fi/∼lainema/mcmc/](http://helios.fmi.fi/%7Elainema/mcmc/){#intref0115}). For the parameter perturbations and bias correction analyses ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}), we fit Model B&D to SMART-seq/SMART-seq2 samples, Model D to all others (including SMART-seq without flanking PCR).

### Note - previous approaches to correct coverage bias {#sec4.4.7}

Correction of RNA-seq coverage bias is necessary in order to yield correct estimates of the original mRNAs' abundances. Effects such as mRNA secondary structure or usage of random-primers with non-uniform nucleotide frequencies will influence the read distributions within transcripts. However, this type of coverage bias affects individual transcripts in a sequence-specific manner. In contrast, the enzymatic bias that we address affects the representation of transcripts in a systematic and length-dependent way; it can result in different shapes of the coverage distribution at different lengths. It is equally possible that the shape stays the same while the total expected read numbers per transcript vary greatly and/or disproportionately for different lengths. Successful correction of this bias thus requires an understanding of the actual, potentially non-linear, scaling between numbers of sequencing reads mapping to transcripts and their lengths. While several methods to correct RNA-seq coverage bias have been published, they mostly fall short with regards to this last point.

Most methods follow the same overall strategy of re-weighing read densities along transcripts based on functions that describe their deviance from uniform distributions. These functions range from non-parametric empirical to stepwise linear to Gaussian mixture models and others ([@bib5], [@bib29], [@bib18], [@bib55], [@bib19], [@bib40], [@bib28], [@bib20], [@bib49]). The approaches also differ by their resolution (bins, sections, single bases, etc.), by how the functions are learned, and whether/how the functions are allowed to vary with transcript length. However, none of these methods offer mechanistic insights or scale across transcripts as explained above since they are not based on an understanding of the logics underlying library preparation.

An approach that suffers from similar problems but takes into account scaling across transcripts is provided by [@bib56]. The authors aim to remove length-related bias, which is implicitly based on the assumption that mRNA length and expression levels are independent variables. It is not clear that this would be so as, biologically, restricting expression of long transcripts might be energetically favorable; in line with this, even the (largely systematic bias-free-) RNA-fragmentation protocol displays anti-correlation between length and expression level ([Figure S8](#mmc1){ref-type="supplementary-material"}b, Vahedi dataset). Also, we have observed anti-correlation between gene length and expression level in most datasets after correcting for the length bias using our methodology ([Figure S8](#mmc1){ref-type="supplementary-material"}b).

Noteworthy is also the approach of [@bib52], who correct FPKM within exons by a factor that is taken to exponentially decrease from the 3′ ends to the center of each exon. This is somewhat similar to our model B ([Figure 1](#fig1){ref-type="fig"}D), although their factor is fitted separately for each gene. The authors interpret the exponential decrease as mRNA decay, which appears implausible for a number of reasons; RNA degradation during experimental procedures is improbable to occur from one side only and/or to occur at rates that correlate across datasets ([@bib52]). Biological degradation, on the other hand, is unlikely to lead to a simple exponential decrease; processive, one-sided degradation should theoretically yield a shape corresponding $1 - e^{- \delta x}$(*δ* being the degradation rate), if detectable at all; biological mRNA degradation takes place extremely rapidly, usually leaving no detectable intermediates [@bib17]. Note also that coverage bias is not generally limited to one side. We show that the bias can shift from 3′ to 5′ end, or be bimodal, or be absent for the same cell type (Th2 cells, compare the datasets Wei, Hebenstreit, Mahata, Vahedi, respectively) depending on the library preparation protocol ([Figure S1](#mmc1){ref-type="supplementary-material"}). Our model predicts and confirms this effect.

It is worth including a brief discussion of the 'Flux Simulator' ([@bib9]) tool here. Although it is not a bias correction method, it aims to computationally simulate the steps of experimental protocols in terms of their influence on the resulting read distributions. It is used for in silico data generation in several studies and is interesting for its consideration of enzymatic reactions during library preparation. The dependencies of first- and second-strand syntheses on priming strategies are recognized. However, parameter estimations for these are not possible and the software makes extensive simplifications; syntheses endpoints are assumed to be uniformly distributed and are limited to a maximum distance of 5 kb. Over-represented ends of (short) strands upon frequent full-length syntheses are not considered either (compare our density functions for synthesis endpoints, which feature delta peaks at the ends; [Figure S2](#mmc1){ref-type="supplementary-material"}b).

### Models {#sec4.4.8}

#### Preliminaries {#sec4.4.8.1}

We use conditional probabilities for different events within an experimental protocol to derive an expression for the likelihood of a sequencing read start position. For instance, the probability to initiate reverse transcription/first-strand synthesis might depend on the binding probability of a primer to the mRNA, which in turn might depend on the transcript length, etc. These individual dependencies can be conveniently factored following the chain rule to give the joint probability.

For one particular transcript of length $l$, let the possible start- and end-points of first- and second-strand cDNA synthesis be denoted by the random variables $s_{1}$, $e_{1}$, $s_{2}$ and $e_{2}$ (all $\in \mathbb{R}$), respectively, as illustrated in [Figure S2](#mmc1){ref-type="supplementary-material"}a.

To take account of (i) the opposite direction of first- and second-strand syntheses and of (ii) the fact that synthesis necessarily ends at either end of the transcript, the following semi-continuous conditional probability densities are introduced ([Figure S2](#mmc1){ref-type="supplementary-material"}b):$$p\left( {\left. e_{1} \right|s_{1}} \right) = \left\{ \begin{array}{rr}
{\varphi\left( {s_{1} - e_{1},\theta_{1}} \right) + \delta\left( e_{1} \right)\left\lbrack {1 - \Phi\left( {s_{1},\theta_{1}} \right)} \right\rbrack} & {\text{if}\ 0 \leq e_{1} \leq s_{1} \leq l,} \\
0 & {\text{otherwise}.} \\
\end{array} \right.$$and$$p\left( {\left. e_{2} \right|s_{2}} \right) = \left\{ \begin{array}{rr}
{\varphi\left( {e_{2} - s_{2},\theta_{2}} \right) + \delta\left( {e_{2} - l} \right)\left\lbrack {1 - \Phi\left( {l - s_{2},\theta_{2}} \right)} \right\rbrack} & {\text{if}\ 0 \leq s_{2} \leq e_{2} \leq l,} \\
0 & {\text{otherwise}.} \\
\end{array} \right.$$

Here, $\varphi$ gives probability densities for the synthesis lengths of first- and second-strand enzymes (reverse transciptase and DNA polymerase), respectively, and $\Phi$ gives the corresponding cumulative distribution functions. $\delta\left( x \right)$ represented the Dirac delta function. The distributions are subject to parameters $\theta_{1}$ and $\theta_{2}$, and can be assumed to be exponential distributions based on what is known for the processivity of polymerases ([Figure S2](#mmc1){ref-type="supplementary-material"}b; in the case of concatenates of several individual polymerization processes, sums of exponentially distributed variables will result, forming Erlang distributions).

We then have$$\varphi\left( {x,\theta} \right) = \theta e^{- \theta x};\quad\Phi\left( {x,\theta} \right) = 1 - e^{- \theta x}.$$

Given the above conditional probabilities, in the following we will use the following relation:$$p\left( {s_{1},e_{1},s_{2},e_{2}} \right) = p\left( {\left. e_{2} \right|s_{2},s_{1}} \right)p\left( {\left. s_{2} \right|e_{1},s_{1}} \right)p\left( {\left. e_{1} \right|s_{1}} \right)p\left( s_{1} \right).$$

If as in the models A to D ([Figure 1](#fig1){ref-type="fig"}D), we have $p\left( s_{1} \right) = \delta\left( {s_{1} - l} \right)$, the dependence of $s_{2}$ and $e_{2}$ on $s_{1}$ is dropped. In many protocols the cDNA is fragmented before sequencing. We assume there is uniform probability of fragmentation along the cDNA and therefore there is also uniform probability of a sequencing start read along the transcript's length. However, we assume that fragmentation efficiency is reduced for positions closer than a distance $h$ from either end, thus resulting in lower sequencing coverage. We calculate the likelihood of a sequencing read on a fragmented end of a cDNA in either direction for a given mRNA as$$f_{frag}\left( x \right) = \left( \begin{matrix}
{\frac{1}{d}\mathsf{P}\left( {s_{2} < x < e_{2}} \right) + \mathsf{P}\left( {s_{2} + h < x < e_{2} - h} \right)} & {\text{for}\ h < x < l - h,} \\
{\frac{1}{d}\mathsf{P}\left( {s_{2} < x < e_{2}} \right)} & {\text{otherwise}.} \\
\end{matrix} \right.$$

Coverage inside fragments is thus assumed to be higher by a factor $\left( {d + 1} \right)$ than close to ends (we assume $d > 0$).

In the following, we derive analytical expressions for the likelihood function for several models of how library preparation of various RNA-seq protocols takes place ([Figure 1](#fig1){ref-type="fig"}D in the main text).

#### Derivations of Models {#sec4.4.8.2}

Symbolic calculations of the derivations below were carried out with *Mathematica* software and were checked manually where feasible.

##### Derivation of Model A {#sec4.4.8.3.1}

This model is compatible with idealistic assumptions about SMART-based protocols; first-strand synthesis is primed with oligo(dT) primers and thus starts at the 3′ end of transcripts (i.e., at position $l$). Only first-strands reaching the 5′ ends of transcripts are primed for second-strand synthesis at position 0. Only second-strands reaching position $l$ are processed for sequencing. Therefore:$$p\left( s_{1} \right) = \delta\left( {s_{1} - l} \right)\ \text{and}\ p\left( {\left. s_{2} \right|e_{1}} \right) = \delta\left( e_{1} \right)\delta\left( s_{2} \right).$$

We have for for $h < x < l - h$$$\mathsf{P}_{A}\left( {s_{2} + h < x < e_{2} - h} \right) = {\int_{0}^{l}{p\left( {s_{2} + h < x < e_{2} - h} \right)p\left( {s_{1},e_{1},s_{2},e_{2}} \right)ds_{1}de_{1}ds_{2}de_{2}}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}\delta\left( {e_{2} - l} \right)}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}p\left( {e_{2},s_{2},e_{1},s_{1}} \right)}}$$$$= {\int_{0}^{l}{de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}\delta\left( {e_{2} - l} \right)}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}p\left( {\left. e_{2} \right|s_{2}} \right)p\left( {\left. s_{2} \right|e_{1}} \right)p\left( {\left. e_{1} \right|l} \right)}}$$$$= {\int_{x + h}^{l}{de_{2}\delta\left( {e_{2} - l} \right)}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}p\left( {\left. e_{2} \right|s_{2}} \right)\delta\left( s_{2} \right)\left\lbrack {1 - \Phi\left( {l,\theta_{1}} \right)} \right\rbrack}}$$$$= \left\lbrack {1 - \Phi\left( {l,\theta_{1}} \right)} \right\rbrack\ \left\lbrack {1 - \Phi\left( {l,\theta_{2}} \right)} \right\rbrack$$$$= e^{- l{({\theta_{1} + \theta_{2}})}}.$$

We note that for $h > x$ or $x > l - h$ we have$$\mathsf{P}_{A}\left( {s_{2} + h < x < e_{2} - h} \right) = 0.$$

We note that the integrals above are a continuous approximation of the discrete sums over mRNA residues that includes the 3′ and 5′ end of the mRNA. So, the integral limits are from $0 - \varepsilon$ to $l + \varepsilon$, where ε is a small positive real number. Throughout, these limits are taken into account when integrating over the Dirac *δ* functions but for simplicity the $\varepsilon$'s are not explicitly included.

##### Derivation of Model B {#sec4.4.8.3.2}

This model is compatible with idealistic assumptions about poly-A-tagging protocols; first-strand synthesis is primed with oligo(dT) primers and thus starts at the 3′ end of transcripts (i.e., at position $l$). Second-strand synthesis starts at the end of first-strands. Only second-strands reaching position $l$ are processed for sequencing. Therefore:$$p\left( s_{1} \right) = \delta\left( {s_{1} - l} \right)\ \text{and}\ p\left( {\left. s_{2} \right|e_{1}} \right) = \delta\left( {s_{2} - e_{1}} \right).$$

We have for $h < x < l - h$$$\mathsf{P}_{B}\left( {s_{2} + h < x < e_{2} - h} \right) = {\int_{0}^{l}{p\left( {s_{2} + h < x < e_{2} - h} \right)p\left( {s_{1},e_{1},s_{2},e_{2}} \right)ds_{1}de_{1}ds_{2}de_{2}}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}\ \delta\left( {e_{2} - l} \right)}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}p\left( {e_{2},s_{2},e_{1},s_{1}} \right)}}$$$$= {\int_{0}^{l}{de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}\ \delta\left( {e_{2} - l} \right)}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}p\left( {\left. e_{2} \right|s_{2}} \right)p\left( {\left. s_{2} \right|e_{1}} \right)p\left( {\left. e_{1} \right|l} \right)}}$$$$= {\int_{x + h}^{l}{de_{2}\ \delta\left( {e_{2} - l} \right)}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}p\left( {\left. e_{2} \right|s_{2}} \right)p\left( {\left. s_{2} \right|l} \right)}}$$$$= {\int_{0}^{x - h}{ds_{2}\ p\left( {\left. s_{2} \right|l} \right)}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}\ \delta\left( {e_{2} - l} \right)p\left( {\left. e_{2} \right|s_{2}} \right)}}$$$$= {\int_{0}^{x - h}{ds_{2}\ p\left( {\left. s_{2} \right|l} \right)p\left( {\left. l \right|s_{2}} \right)}}$$$$= {\int_{0}^{x - h}{ds_{2}\ p\left( {\left. s_{2} \right|l} \right)\left\lbrack {1 - \Phi\left( {l - s_{2},\theta_{2}} \right)} \right\rbrack}}$$$$= \frac{1}{\left( {\theta_{1} + \theta_{2}} \right)}\left\lbrack {\theta_{1}e^{- 2l{({\theta_{1} + \theta_{2}})} + {({\theta_{1} + \theta_{2}})}{({l - h + x})}} + \theta_{2}e^{- l{({\theta_{1} + \theta_{2}})}}} \right\rbrack.$$

We note again that for $h > x$ or $x > l - h$ we have$$\mathsf{P}_{B}\left( {s_{2} + h < x < e_{2} - h} \right) = 0.$$

##### Derivation of Model C {#sec4.4.8.3.3}

This model assumes that full-length first-strands are selected, while second-strand synthesis may be incomplete; first-strand synthesis is primed with oligo(dT) primers and thus starts at the 3′ end of transcripts (i.e., at position $l$). Only first-strands reaching the 5′ ends of transcripts are primed for second-strand synthesis at position 0. Therefore:$$p\left( s_{1} \right) = \delta\left( {s_{1} - l} \right)\ \text{and}\ p\left( {\left. s_{2} \right|e_{1}} \right) = \delta\left( e_{1} \right)\delta\left( s_{2} \right).$$

We have for for $h < x < l - h$$$\mathsf{P}_{C}\left( {s_{2} + h < x < e_{2} - h} \right) = {\int_{0}^{l}{p\left( {s_{2} + h < x < e_{2} - h} \right)p\left( {s_{1},e_{1},s_{2},e_{2}} \right)ds_{1}de_{1}ds_{2}de_{2}}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}\ p\left( {e_{2},s_{2},e_{1},s_{1}} \right)}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}\ p\left( {\left. e_{2} \right|s_{2}} \right)p\left( {\left. s_{2} \right|e_{1}} \right)p\left( {\left. e_{1} \right|s_{1}} \right)p\left( s_{1} \right)}}$$$$= \left\lbrack {1 - \Phi\left( {l,\theta_{1}} \right)} \right\rbrack\ \left\lbrack {1 - \Phi\left( {x + h,\theta_{2}} \right)} \right\rbrack$$$$= e^{- \theta_{1}l - \theta_{2}{({x + h})}}.$$

We again note that for $h > x$ or $x > l - h$ we have$$\mathsf{P}_{C}\left( {s_{2} + h < x < e_{2} - h} \right) = 0.$$

##### Derivation of Model D {#sec4.4.8.3.5}

This model assumes that no selection for full-length syntheses takes place and is compatible with imperfect SMART or poly-A-tagging protocols; first-strand synthesis is primed with oligo(dT) primers and thus starts at the 3′ end of transcripts (i.e., at position $l$). Second-strand synthesis starts at the end of first-strands. Therefore:$$p\left( s_{1} \right) = \delta\left( {s_{1} - l} \right)\ \text{and}\ p\left( {\left. s_{2} \right|e_{1}} \right) = \delta\left( {s_{2} - e_{1}} \right).$$

We have for $h < x < l - h$$$\mathsf{P}_{D}\left( {s_{2} + h < x < e_{2} - h} \right) = {\int_{0}^{l}{p\left( {s_{2} + h < x < e_{2} - h} \right)p\left( {s_{1},e_{1},s_{2},e_{2}} \right)ds_{1}de_{1}ds_{2}de_{2}}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}p\left( {e_{2},s_{2},e_{1},s_{1}} \right)}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}\ p\left( {\left. e_{2} \right|s_{2}} \right)p\left( {\left. s_{2} \right|e_{1}} \right)p\left( {\left. e_{1} \right|s_{1}} \right)p\left( s_{1} \right)}}$$$$= {\int_{0}^{x - h}{ds_{2}\left\lbrack {p\left( {\left. {e_{1} = s_{2}} \right|s_{1} = l} \right)\mspace{9mu}{\int_{x + h}^{l}{de_{2}p\left( {\left. e_{2} \right|s_{2}} \right)}}} \right\rbrack}}$$$$= {\int_{0}^{x - h}{ds_{2}\left\lbrack {p\left( {\left. {e_{1} = s_{2}} \right|s_{1} = l} \right)\left\lbrack {1 - \Phi\left( {x + h - s_{2},\theta_{2}} \right)} \right\rbrack} \right\rbrack}}$$$$= {\int_{0}^{x - h}{\varphi\left( {l - s_{2},\theta_{1}} \right)\left\lbrack {1 - \Phi\left( {x + h - s_{2},\theta_{2}} \right)} \right\rbrack ds_{2}}}$$$$+ \left\lbrack {1 - \Phi\left( {l,\theta_{1}} \right)} \right\rbrack\ \left\lbrack {1 - \Phi\left( {x + h,\theta_{2}} \right)} \right\rbrack$$$$= \frac{\theta_{1}}{\theta_{1} + \theta_{2}}\left\lbrack {e^{- \theta_{1}{({l - x})} - \theta_{1}h - 2\theta_{2}h} - e^{- \theta_{1}l - \theta_{2}{({x + h})}}} \right\rbrack + e^{- \theta_{1}l - \theta_{2}{({x + h})}}$$$$= \frac{1}{\theta_{1} + \theta_{2}}\left\lbrack {\theta_{1}e^{- \theta_{1}{({l - x})} - \theta_{1}h - 2\theta_{2}h} + \theta_{2}e^{- \theta_{1}l - \theta_{2}{({x + h})}}} \right\rbrack.$$

We note that for $h > x$ or $x > l - h$ we have$$\mathsf{P}_{D}\left( {s_{2} + h < x < e_{2} - h} \right) = 0.$$

##### Derivation of Model E {#sec4.4.8.3.6}

This model is based on random-primed first- and second-strand syntheses. To model first-strand priming, we set$$p\left( s_{1} \right) = \left\{ \begin{array}{rr}
\alpha_{1} & {\text{if}\ 0 \leq s_{1} \leq l,} \\
0 & {\text{otherwise}.} \\
\end{array} \right.$$where, $l$ is the length of mRNA as before and $\alpha_{1}$ is the probability of primer binding per position. Second-strand priming is usually carried out by (random) RNaseH nicking, so we have similarly$$p\left( {\left. s_{2} \right|e_{1},s_{1}} \right) = \left\{ \begin{array}{rr}
\alpha_{2} & {\text{if}\ e_{1} \leq s_{2} \leq s_{1},} \\
0 & {\text{if}\ s_{2} < e_{1}\text{or}s_{2} > s_{1}.} \\
\end{array} \right.$$

We assume that multiple priming events on the same first- and/or second-strand are possible. We approximate the effects of this by assuming it will reduce the average syntheses lengths, yielding modified processivity parameters $\theta_{1^{\prime}}$ and $\theta_{2^{\prime}}$. We have:$$p\left( {\left. e_{1} \right|s_{1}} \right) = \left\{ \begin{array}{rr}
{\varphi_{1}\left( {s_{1} - e_{1},\theta_{1}^{\prime}} \right) + \delta\left( e_{1} \right)\left\lbrack {1 - \Phi_{1}\left( {s_{1},\theta_{1}^{\prime}} \right)} \right\rbrack} & {\text{if}\ 0 \leq e_{1} \leq s_{1},} \\
0 & {\text{otherwise}.} \\
\end{array} \right.$$and$$p\left( {\left. e_{2} \right|s_{2},s_{1}} \right) = \left\{ \begin{array}{rr}
{\varphi_{2}\left( {e_{2} - s_{2},\theta_{2}^{\prime}} \right) + \delta\left( {e_{2} - s_{1}} \right)\left\lbrack {1 - \Phi_{2}\left( {s_{1} - s_{2},\theta_{2}^{\prime}} \right)} \right\rbrack} & {\text{if}\ s_{2} \leq e_{2} \leq s_{1},} \\
0 & {\text{if}\ s_{2} > e_{2}\ \text{or}\ e_{2} > s_{1}.} \\
\end{array} \right.$$

As we are assuming synthesis length follows an exponential decay, the new decay lengths can simply be related to the original ones:$$\theta_{1}^{\prime} = \theta_{1} + \alpha_{1},$$$$\theta_{2}^{\prime} = \theta_{2} + \alpha_{2}.$$

Using the above probabilities, similar to the last sections, we can calculate the probabilities that are required to derive the likelihoods.

We have for for $h < x < l - h$$$\mathsf{P}_{E}\left( {s_{2} + h < x < e_{2} - h} \right) = {\int_{0}^{l}{p\left( {s_{2} + h < x < e_{2} - h} \right)p\left( {s_{1},e_{1},s_{2},e_{2}} \right)ds_{1}de_{1}ds_{2}de_{2}}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}\ p\left( {e_{2},s_{2},e_{1},s_{1}} \right)}}$$$$= {\int_{0}^{l}{ds_{1}de_{1}}}\mspace{9mu}{\int_{x + h}^{l}{de_{2}}}\mspace{9mu}{\int_{0}^{x - h}{ds_{2}\ p\left( {\left. e_{2} \right|s_{2},s_{1}} \right)p\left( {\left. s_{2} \right|e_{1},s_{1}} \right)p\left( {\left. e_{1} \right|s_{1}} \right)p\left( s_{1} \right)}}$$$$= \alpha_{1}\alpha_{2}\mspace{9mu}{\int_{x + h}^{l}{ds_{1}}}\mspace{9mu}{\int_{0}^{x - h}{de_{1}}}\mspace{9mu}{\int_{e_{1}}^{x - h}{ds_{2}}}\mspace{9mu}{\int_{x + h}^{s_{1}}{de_{2}\left\lbrack {\varphi\left( {e_{2} - s_{2},\theta_{2}^{\prime}} \right)} \right.}}$$$$\left. {+ \delta\left( {e_{2} - s_{1}} \right)\left\lbrack {1 - \Phi\left( {s_{1} - s_{2},\theta_{2}^{\prime}} \right)} \right\rbrack} \right\rbrack\ \left\lbrack {\varphi\left( {s_{1} - e_{1},\theta_{1}^{\prime}} \right) + \delta\left( e_{1} \right)\left\lbrack {1 - \Phi\left( {s_{1},\theta_{1}^{\prime}} \right)} \right\rbrack} \right\rbrack$$$$= \frac{\alpha_{1}\alpha_{2}}{\theta_{1}^{\prime}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)}e^{- {({2h + l + x})}\theta_{1}^{\prime} - {({2h + x})}\theta_{2}^{\prime}}\left( {e^{l\theta_{1}^{\prime}} - e^{{(h + x)}\theta_{1}^{\prime}}} \right)\left( {e^{x{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}} - e^{h{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}}} \right).$$

We again note that for $h > x$ or $x > l - h$ we have$$\mathsf{P}_{E}\left( {s_{2} + h < x < e_{2} - h} \right) = 0.$$

##### Derivation of Mixture model B&D {#sec4.4.8.3.7}

For this model, we assume that a partial selection of full-length second-strands takes place based on PCR using 3′ flanking primers. This corresponds to a mixture of models B and D:$$\mathsf{P}_{B\& D}\left( {s_{2} + h < x < e_{2} - h} \right) = \alpha\mathsf{P}_{B} + \left( {1 - \alpha} \right)\mathsf{P}_{D},\mspace{9mu} 0 \leq \alpha \leq 1.$$

#### Model summary and correction (normalization) factors {#sec4.4.8.9}

##### Model A {#sec4.4.8.9.1}

Fragmentation model / Coverage function$$f_{frag}\left( x \right) = \left( \begin{matrix}
{\left( {\frac{1}{d} + 1} \right)e^{- l{({\theta_{1} + \theta_{2}})}}} & {\text{for}\ h < x < l - h,} \\
{\frac{1}{d}e^{- l{({\theta_{1} + \theta_{2}})}}} & {\text{otherwise}.} \\
\end{matrix} \right.$$

Area under coverage function$${\int_{0}^{l}{f_{frag}\left( x \right)dx}} = \left( \begin{matrix}
{\frac{l + d\left( {l - 2h} \right)}{d}e^{- l{({\theta_{1} + \theta_{2}})}}} & {\text{for}\ h < \frac{l}{2},} \\
{\frac{l}{d}e^{- l{({\theta_{1} + \theta_{2}})}}} & {\text{otherwise}.} \\
\end{matrix} \right.$$

##### Model B {#sec4.4.8.9.2}

Fragmentation model / Coverage function$$f_{frag}\left( x \right) = \left( \begin{matrix}
{\frac{1}{d\left( {\theta_{1} + \theta_{2}} \right)}\left\lbrack {\theta_{1}e^{- 2l{({\theta_{1} + \theta_{2}})} + {({\theta_{1} + \theta_{2}})}{({l + x})}} + \theta_{2}e^{- l{({\theta_{1} + \theta_{2}})}}} \right\rbrack + \frac{1}{\left( {\theta_{1} + \theta_{2}} \right)}\left\lbrack {\theta_{1}e^{- 2l{({\theta_{1} + \theta_{2}})} + {({\theta_{1} + \theta_{2}})}{({l - h + x})}} + \theta_{2}e^{- l{({\theta_{1} + \theta_{2}})}}} \right\rbrack} & {\text{for}\ h < x < l - h,} \\
{\frac{1}{d\left( {\theta_{1} + \theta_{2}} \right)}\left\lbrack {\theta_{1}e^{- 2l{({\theta_{1} + \theta_{2}})} + {({\theta_{1} + \theta_{2}})}{({l + x})}} + \theta_{2}e^{- l{({\theta_{1} + \theta_{2}})}}} \right\rbrack} & {\text{otherwise}.} \\
\end{matrix} \right.$$

Area under coverage function$${\int_{0}^{l}{f_{frag}\left( x \right)dx}} = \left( \begin{matrix}
{\frac{1}{d\left( {\theta_{1} + \theta_{2}} \right)^{2}}\left\lbrack {\theta_{1} + e^{- l{({\theta_{1} + \theta_{2}})}}\left( {l\theta_{2}^{2} + l\theta_{1}\theta_{2} - \theta_{1}} \right)} \right\rbrack + \frac{\theta_{1}\left( {e^{- 2h{({\theta_{1} + \theta_{2}})}} - e^{- l{({\theta_{1} + \theta_{2}})}}} \right) + \theta_{2}\left( {\theta_{1} + \theta_{2}} \right)\left( {l - 2h} \right)e^{- l{({\theta_{1} + \theta_{2}})}}}{\left( {\theta_{1} + \theta_{2}} \right)^{2}}} & {\text{for}\ h < \frac{l}{2},} \\
{\frac{1}{d\left( {\theta_{1} + \theta_{2}} \right)^{2}}\left\lbrack {\theta_{1} + e^{- l{({\theta_{1} + \theta_{2}})}}\left( {l\theta_{2}^{2} + l\theta_{1}\theta_{2} - \theta_{1}} \right)} \right\rbrack} & {\text{otherwise}.} \\
\end{matrix} \right.$$

##### Model C {#sec4.4.8.9.3}

Fragmentation model / Coverage function$$f_{frag}\left( x \right) = \left( \begin{matrix}
{\frac{1}{d}e^{- \theta_{1}l - \theta_{2}x} + e^{- \theta_{1}l - \theta_{2}{({x + h})}}} & {\text{for}\ h < x < l - h,} \\
{\frac{1}{d}e^{- \theta_{1}l - \theta_{2}x}} & {\text{otherwise}.} \\
\end{matrix} \right.$$

Area under coverage function$${\int_{0}^{l}{f_{frag}\left( x \right)dx}} = \left( \begin{matrix}
{\frac{e^{- l\theta_{1}}\left( {1 - e^{- l\theta_{2}}} \right)}{d\theta_{2}} + \frac{e^{- l\theta_{1}}\left( {e^{- 2h\theta_{2}} - e^{- l\theta_{2}}} \right)}{\theta_{2}}} & {\text{for}\ h < \frac{l}{2},} \\
\frac{e^{- l\theta_{1}}\left( {1 - e^{- l\theta_{2}}} \right)}{d\theta_{2}} & {\text{otherwise}.} \\
\end{matrix} \right.$$

##### Model D {#sec4.4.8.9.4}

Fragmentation model / Coverage function$$f_{frag}\left( x \right) = \left( \begin{matrix}
{\frac{1}{d\left( {\theta_{1} + \theta_{2}} \right)}\left\lbrack {\theta_{1}e^{- \theta_{1}{({l - x})}} + \theta_{2}e^{- \theta_{1}l - \theta_{2}x}} \right\rbrack + \frac{1}{\theta_{1} + \theta_{2}}\left\lbrack {\theta_{1}e^{- \theta_{1}{({l - x})} - \theta_{1}h - 2\theta_{2}h} + \theta_{2}e^{- \theta_{1}l - \theta_{2}{({x + h})}}} \right\rbrack} & {\text{for}\ h < x < l - h,} \\
{\frac{1}{d\left( {\theta_{1} + \theta_{2}} \right)}\left\lbrack {\theta_{1}e^{- \theta_{1}{({l - x})}} + \theta_{2}e^{- \theta_{1}l - \theta_{2}x}} \right\rbrack} & {\text{otherwise}.} \\
\end{matrix} \right.$$

Area under coverage function$${\int_{0}^{l}{f_{frag}\left( x \right)dx}} = \left( \begin{matrix}
{\frac{1 - e^{- l{({\theta_{1} + \theta_{2}})}}}{d\left( {\theta_{1} + \theta_{2}} \right)} + \frac{e^{- 2h{({\theta_{1} + \theta_{2}})}} - e^{- l{({\theta_{1} + \theta_{2}})}}}{\theta_{1} + \theta_{2}}} & {\text{for}\ h < \frac{l}{2},} \\
\frac{1 - e^{- l{({\theta_{1} + \theta_{2}})}}}{d\left( {\theta_{1} + \theta_{2}} \right)} & {\text{otherwise}.} \\
\end{matrix} \right.$$

##### Model E {#sec4.4.8.9.5}

Fragmentation model / Coverage function$$f_{frag}\left( x \right) = \left( \begin{matrix}
{\frac{\alpha_{1}\alpha_{2}}{d\theta_{1}^{\prime}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)}\left( {1 - e^{- x{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}} - e^{- {({l - x})}\theta_{1}^{\prime}} + e^{- l\theta_{1}^{\prime} - x\theta_{2}^{\prime}}} \right)} & \\
{+ \frac{\alpha_{1}\alpha_{2}}{\theta_{1}^{\prime}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)}\left( {e^{- 2h{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}} - e^{- {({h + x})}{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}} - e^{- 2h\theta_{2}^{\prime} - {({l + h - x})}\theta_{1}^{\prime}} + e^{- l\theta_{1}^{\prime} - {({h + x})}\theta_{2}^{\prime}}} \right)} & {\text{for}\ h < x < l - h,} \\
{\frac{\alpha_{1}\alpha_{2}}{d\theta_{1}^{\prime}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)}\left( {1 - e^{- x{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}} - e^{- {({l - x})}\theta_{1}^{\prime}} + e^{- l\theta_{1}^{\prime} - x\theta_{2}^{\prime}}} \right)} & {\text{otherwise}.} \\
\end{matrix} \right.$$

Area under coverage function$${\int_{0}^{l}{f_{frag}\left( x \right)dx}} = \left( \begin{array}{ll}
{\frac{\alpha_{1}\alpha_{2}}{d\theta_{1}^{\prime}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)}\left\lbrack {l - \frac{1}{\theta_{1}^{\prime} + \theta_{2}^{\prime}} - \frac{1}{\theta_{1}^{\prime}} - \frac{\theta_{1}^{\prime}e^{- l{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}}}{\theta_{2}^{\prime}\left( \theta_{1}^{\prime} + \theta_{2}^{\prime} \right)} + \frac{\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)\quad e^{- l\theta_{1}^{\prime}}}{\theta_{1}^{\prime}\theta_{2}^{\prime}}} \right\rbrack} & \\
{+ \frac{\alpha_{1}\alpha_{2}}{\theta_{1}^{2^{\prime}}\theta_{2}^{\prime}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)^{2}}\left\lbrack {e^{- l\theta_{1}^{\prime} - 2h\theta_{2}^{\prime}}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)^{2} - e^{- l{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}}\theta_{1}^{2^{\prime}} + \theta_{1}^{\prime}\theta_{2}^{\prime}e^{- 2h{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}}\left( {l\theta_{2}^{\prime} - 2h\theta_{1}^{\prime} - 2h\theta_{2}^{\prime} + l\theta_{1}^{\prime} - \theta_{2}^{\prime}/\theta_{1}^{\prime} - 2} \right)} \right\rbrack} & {\text{for}\ h < \frac{l}{2},} \\
{\frac{\alpha_{1}\alpha_{2}}{d\theta_{1}^{\prime}\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)}\left\lbrack {l - \frac{1}{\theta_{1}^{\prime} + \theta_{2}^{\prime}} - \frac{1}{\theta_{1}^{\prime}} - \frac{\theta_{1}^{\prime}e^{- l{({\theta_{1}^{\prime} + \theta_{2}^{\prime}})}}}{\theta_{2}^{\prime}\left( \theta_{1}^{\prime} + \theta_{2}^{\prime} \right)} + \frac{\left( {\theta_{1}^{\prime} + \theta_{2}^{\prime}} \right)\quad e^{- l\theta_{1}^{\prime}}}{\theta_{1}^{\prime}\theta_{2}^{\prime}}} \right\rbrack} & {\text{otherwise}.} \\
\end{array} \right.$$

##### Mixture model B&D {#sec4.4.8.9.6}

Fragmentation model and correction (normalization) factor correspond to the weighted sum as given above in the derivation of the mixture of models B&D.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical parameters and statistical significance are reported in the figures and figure legends. Data were in general judged to be statistically significant when p \< 0.05 using the statistical tests are described in figure legends. Where data were suspected not to be normally distributed, Mann Whitney U (unpaired data) and Wilcoxon signed-rank tests (paired data) were used as appropriate and as identified in the figure legends; otherwise one-sided t tests were used as indicated in the figure legends. Trendlines are based on straight-line fits calculated with Mathematica or *R* as described in the method text and figure legends where relevant. Correlations in [Figure 4](#fig4){ref-type="fig"}D were calculated with Mathematica 10 and are the Pearson product-moment correlation coefficient.

Data and Software Availability {#sec4.6}
------------------------------

### Data Resources {#sec4.6.1}

The accession number for the raw and processed data files for the RNA sequencing analysis reported in this paper is NCBI GEO: [GSE84785](ncbi-geo:GSE84785){#intref0120}.
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![cDNA Conversion Yields Biases of RNA-Seq Coverage\
(A) Library preparation for next-generation sequencing involves reverse transcription and second-strand synthesis, followed by fragmentation. Depending on the protocol, reverse-transcription starts and ends at certain points for first-strand synthesis (*s*~1~ and *e*~1~, respectively) and second-strand synthesis (*s*~2~ and *e*~2~).\
(B) The original mRNA (olive) is thus often non-uniformly represented by double-stranded cDNA (orange), which biases detection by RNA-seq (blue).\
(C) RNA-seq coverage along transcripts for different datasets. Sequencing reads were mapped to murine, non-overlapping RefSeq transcripts without isoforms. All detected transcripts (∼10,000) were ordered from shortest (top) to longest (bottom), were adjusted to have identical length, and were divided into 20 bins each. The percentage of reads in each bin is color coded for each transcript (see legend). The distribution of transcript lengths is shown on log scale on the left. This distribution corresponds to the Wold dataset but is representative of the others, subject to minor variations due to different numbers of detected transcripts. Details of the datasets shown are listed in [Table 1](#tbl1){ref-type="table"}. Unbiased coverage within transcripts would result in uniformly orange rectangles. More datasets are shown in [Figure S1](#mmc1){ref-type="supplementary-material"}.\
(D) Simplified models/scenarios of RNA-seq library preparation outcomes based on priming strategy and synthesis success.](gr1){#fig1}

![Analysis and Fitting of Models\
(A) Coverage heatmaps as in [Figure 1](#fig1){ref-type="fig"}C for theoretical models A--E ([Table 2](#tbl2){ref-type="table"}), using parameter settings as indicated on the right side. The transcript length distribution of the Wold dataset was used.\
(B) Overlays of best fitting models (dashed lines) after Markov Chain Monte Carlo (MCMC) parameter estimation for three different models (D, B&D, and E; left, middle, and right, respectively) for two datasets (Wold, left and middle; Hebenstreit.a, right). Solid lines are kernel density estimates for sequencing read starting positions for different length categories (color code, inset), each containing data for all mRNAs with lengths within 10% of the length category.\
(C) MCMC parameter estimates for a selection of SMART and poly-A-tagging datasets. The bar heights correspond to the medians; the error bars correspond to the median absolute deviations.\
(D) MCMC parameter estimates for *α* for four datasets, Bhargava.AA/SMF.ng/pg. AA (Activin A) and SFM (serum-free media) are two different biological samples, which were subjected to 14 or 18 PCR cycles during library preparation as indicated. The bar heights correspond to the medians; the error bars correspond to the median absolute deviations. ^∗∗∗^p \< 10^−9^, Mann-Whitney U test.](gr2){#fig2}

![Model Correctly Infers Increased Enzyme Processivities upon Lowered Reaction Temperatures\
(A) MCMC parameter estimates for *θ*~1~ for diverse RNA-seq samples ([Table S1](#mmc1){ref-type="supplementary-material"}, color code on bottom of figure) prepared with altered reaction temperatures during first- and second-strand syntheses. "Standard" temperatures were 42°C and 72°C for first- and second-strand, respectively, which were lowered to 25°C and 42°C, respectively, in the designated samples (black horizontal lines indicate the median; ^∗^p ≤ 0.051, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001, one-sided Wilcoxon signed-rank test).\
(B) As (A) for *θ*~2~.\
(C) cDNA yield increases upon altered reaction temperatures. Starting amounts were 100 ng mRNA in all samples. DNA mass was measured by Qubit (which does not detect RNA). ^∗∗∗^p ≤ 0.001, one-sided t test.\
(D) Fraction of reads mapping to transcripts in different length categories (0--2 kb, 2--4 kb, ..., 10--12 kb; \>12 kb not included in figure) were determined for sequencing samples with lowered incubation temperatures (first- and second-strand synthesis at 25°C and 42°C, respectively) as indicated by color code at the bottom of the figure. The fractions were then normalized to the corresponding length category for standard incubation temperatures. ^∗∗∗^p ≤ 0.001, Mann-Whitney U test.\
(E) Increased numbers of genes are detected upon lowered incubation temperatures. The log~2~ ratio of the numbers of detected genes for reduced temperature versus standard temperatures is shown for different RNA-seq samples as indicated by color code at the bottom. The black horizontal line indicates the median.\
(F) Increased total sequencing read numbers map to mRNAs upon lowered incubation temperatures. The log~2~ ratio of read numbers for reduced temperature versus standard temperatures for different RNA-seq samples as indicated by color code at the bottom is shown. The black horizontal line indicates the median.\
(G) Same as (F) for ERCC-mix1 spike-in probes.\
(H) Detection of ERCC-mix1 spike-in probes versus nominal concentrations for diverse sequencing samples (color code at bottom). Bar heights in bar charts corresponds to the mean of independent replicates (three in C). Error bars correspond to sample SD.](gr3){#fig3}

![Quantification Based on Our Novel Modeling Approach\
(A) Length dependency of abundance estimates for our models. The estimates are normalized to unity at length 2 kb. Parameter settings are shown in the table on the right.\
(B) Abundance estimates for RNA spike-ins (ERCC-mix1) of the Wold dataset are plotted versus their lengths for three different bias-correction approaches (Cufflinks, blue; RSEM, green; our model B&D fit, orange). Each dot corresponds to one probe. Fitted trend lines and their formulas are shown. Standardized measures (*Z* scores) are used to make the approaches comparable.\
(C) Abundance estimates for twelve randomly selected mRNAs ([Table S2](#mmc1){ref-type="supplementary-material"}) covering a wide range of lengths. RNA-seq samples deriving from two different RNA samples ([Table S1](#mmc1){ref-type="supplementary-material"}) were quantified by RSEM, Cufflinks, or our model D as indicated. In parallel, the corresponding two RNA samples (dots and triangle symbols, respectively) were subjected to qPCR for the same twelve genes. Presentation and analysis as in (B).\
(D) Correlation matrices for abundance estimates of four datasets for the same cell type (resting Th2 cells) prepared with different library preparation protocols (Hebenstreit.a/b, random priming; Wei, poly-A tagging; Vahedi, RNA fragmentation). Different quantification approaches were used: Cufflinks (left panel), RSEM (middle panel), and our model fittings (Hebenstreit.a/b, model E; Wei, model B&D; Vahedi, model A). See [Table 1](#tbl1){ref-type="table"} for details of the datasets.](gr4){#fig4}

###### 

Previously Published Datasets Used in This Study

  Group                       Name/Reference              Accession Number                     Sample                             Library Protocol         Read Type                                             Read Number   Reads Mapped (%)
  --------------------------- --------------------------- ------------------------------------ ---------------------------------- ------------------------ ----------------------------------------------------- ------------- ------------------
  poly-A tagging              [@bib45]                    GSM365014                            single cell, oocyte                Tang                     50 bases SE, SOLiD                                    25M           36
  [@bib41]                    GSM1036495                  50 cells, embryonic stem cells       Quartz-seq                         102 bases PE, Illumina   85M                                                   96            
  [@bib54]                    GSM523211                   \> μg, resting Th2 cells             Tang                               36 bases SE, Illumina    11M                                                   57            
  SMART                       Deng.smartseq ([@bib7])     GSM1112540                           single cell, 4-cell stage embryo   Smart-seq                53 bases SE, Illumina                                 27M           42
  Bhargava.AA.ng              GSM1231200                  1 ng                                 Smart-seq                          99 bases SE, Illumina    25M                                                   50            
  Bhargava.SFM.ng             GSM1231198                  1 ng                                 24M                                41                                                                                           
  Bhargava.AA.pg              GSM1231212                  25 pg                                23M                                51                                                                                           
  Bhargava.SFM.pg ([@bib3])   GSM1231210                  25 pg mRNA, embryoid bodies          24M                                41                                                                                           
  Wold (ENCODE project)       ENCSR814JMM                 50 cells, cerebellar granule layer   Smart-seq                          100 bases SE, Illumina   48M                                                   26            
  Deng.smartseq2 ([@bib7])    GSM1278036                  single cell, fibroblast              Smart-seq2                         43 bases SE, Illumina    28M                                                   42            
  [@bib32]                    ERR489030                   single cell, activated Th2 cells     Smart-seq                          75 bases PE, Illumina    23M                                                   23            
  Random priming              Hebenstreit.a               GSM710184                            \> μg, resting Th2 cells           Random priming, RNaseH   36 bases                                              16M           46
  Hebenstreit.b ([@bib16])    GSM710183                   41 bases SE, Illumina                26M                                37                                                                                           
  CEL-seq                     Bhargava.celseq ([@bib3])   GSM1231230                           1 ng mRNA, embryoid bodies         CEL-seq                  100 bases PE, Illumina (3′ read used only)            30M           16
                              Celseq2 ([@bib14])          GSM2076520                           single cell, fibroblast            CEL-seq2                 35 bases (trimmed) PE, Illumina (3′ read used only)   0.65M         40
  RNA fragmentation           [@bib50]                    GSM994539                            \> μg, resting Th2 cells           TruSeq                   100 bases SE, Illumina                                40M           46

SE, single end; PE, paired end.

###### 

Theoretical Expectations, Corresponding to Likelihoods, of Transcript Coverage with Different Models

  Model/Scenario   Coverage Function *f* (*x*, *l*, ...) =
  ---------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  A                $e^{-l{({\mathit{\theta}_{1}+\mathit{\theta}_{2}})}}$
  B                $\frac{1}{\left( {\mathit{\theta}_{1}+\mathit{\theta}_{2}} \right)}\left\lbrack {\mathit{\theta}_{1}e^{-2l{({\mathit{\theta}_{1}+\mathit{\theta}_{2}})}+{({\mathit{\theta}_{1}+\mathit{\theta}_{2}})}{({l+x})}}+\mathit{\theta}_{2}e^{-l{({\mathit{\theta}_{1}+\mathit{\theta}_{2}})}}} \right\rbrack$
  C                $e^{-\mathit{\theta}_{1}l-\mathit{\theta}_{2}x}$
  D                $\frac{1}{\left( {\mathit{\theta}_{1}+\mathit{\theta}_{2}} \right)}\left\lbrack {\mathit{\theta}_{1}e^{-\mathit{\theta}_{1}{({l-x})}}+\mathit{\theta}_{2}e^{-\mathit{\theta}_{1}l-\mathit{\theta}_{2}x}} \right\rbrack$
  E                $\frac{\mathit{\alpha}_{1}\mathit{\alpha}_{2}}{\mathit{\theta}_{1}^{\prime}\left( {\mathit{\theta}_{1}^{\prime}+\mathit{\theta}_{2}^{\prime}} \right)}\left\lbrack {l-\frac{1}{\mathit{\theta}_{1}^{\prime}+\mathit{\theta}_{2}^{\prime}}-\frac{1}{\mathit{\theta}_{1}^{\prime}}-\frac{\mathit{\theta}_{1}^{\prime}e^{-l{({\mathit{\theta}_{1}^{\prime}+\mathit{\theta}_{2}^{\prime}})}}}{\mathit{\theta}_{2}^{\prime}\left( {\mathit{\theta}_{1}^{\prime}+\mathit{\theta}_{2}^{\prime}} \right)}+\frac{\left( {\mathit{\theta}_{1}^{\prime}+\mathit{\theta}_{2}^{\prime}} \right)e^{-l\mathit{\theta}_{1}^{\prime}}}{\mathit{\theta}_{1}^{\prime}\mathit{\theta}_{2}^{\prime}}} \right\rbrack$

Theoretical expectations (likelihood) of transcript coverage with different models ([Figure 1](#fig1){ref-type="fig"}D). *x* is the absolute position within the transcript (*x* = 0 at the 5′ end), *l* is the absolute transcript length ([Figure 1](#fig1){ref-type="fig"}A), and *θ*~1~ and *θ*~2~ are the inverse processivities of first- and second-strand syntheses, respectively. *θ′*~1~ and *θ′*~2~ are modified processivities for model E (see [Method Details](#sec4.4){ref-type="sec"}). *α*~1~ and *α*~2~ are the probabilities of first- and second-strand priming at a certain position, respectively. The fragmentation-related terms and parameters (*d*, *h*) are omitted for clarity.

###### Glossary

cDNASingle- or double-stranded DNA obtained from reverse transcription of mRNA, followed by second-strand synthesis (if double stranded).Conditional probability*P*(*x* \| *y*) is the probability of event "*x*" under the condition that "*y*" has occurred.CoverageThe density of sequencing reads aligning to known bases, usually along exons within gene bodies.First-strand synthesisSame as reverse transcription. Polymerization of a complementary DNA (cDNA) strand along an mRNA by reverse transcriptase.FPKMFragments per kilobase of transcript per million mapped reads. Widely used measure for expression levels determined by RNA-seq.LikelihoodA measure for how well a model agrees with the data.Likelihood ratiosCompares the goodness of fit of two models by calculating the ratio between their likelihoods.Markov Chain Monte CarloClass of methods that allow efficient sampling from a probability distribution and are commonly used to produce estimates of posterior distributions in Bayesian statistics.MCMCSee Markov Chain Monte Carlo.OverhangUnpaired nucleotides resulting in a single-stranded stretch at the 5′ or 3′ end of double-stranded DNA.ParametersValues that our models depend on. They determine the exact shapes of the coverage functions and are learned from a specific dataset through the fitting process (see MCMC). The parameters of our models have intuitive interpretations: *d* + 1 ratio of fragmentation efficiencies inside strands versus close to ends. *h* distance (bases) from ends over which fragmentation efficiency is reduced. 1/*θ*~1~ average synthesis length of reverse transcription (processivity). 1/*θ*~2~ average synthesis length of second-strand synthesis (*processivity*). *α* fraction of PCR-selected full-length strands.Priming strategyThe method by which reverse transcription or second-strand synthesis is primed to initiate the reaction---including sequence-specific primers, Oligo(dT) primers, random primers, or others.ProcessivityThe ability of an enzyme to catalyze consecutive reactions between association and dissociation from its substrate. In our context, we use the term as the average number of nucleotides incorporated (i.e., the synthesized length) in one uninterrupted process (on an infinitely long template).Reverse transcriptionSee First-strand synthesis.Second-strand synthesisPolymerization of a second DNA strand complementary to the first cDNA strand by a DNA polymerase.
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